05-Apr-2018 - Waters Corporation

Waters Corporation to Invest $215 Million in Precision Chemistry Manufacturing in Massachusetts

New State-of-the-Art Facility Will Support Continued Growth and Innovation

Following recent approval by its Board of Directors, Waters Corporation announced plans to significantly expand its precision chemistry operation in Taunton, Mass. The company anticipates investing approximately $215 million to build and equip a new state-of-the-art facility that will support rising global customer demand, as well as ongoing innovation in chemistry technology.

The company's Taunton, Massachusetts site is responsible for bulk synthesis of chromatographic media which is critical to sample analysis for pharmaceutical, biopharmaceutical, materials, food, clinical and biomedical research applications.

"Our portfolio of innovative precision chemistry products is critical to scientific advancements in the life, materials and food sciences," said Christopher J. O'Connell, Waters Corporation Chairman and CEO. The expansion of our Taunton facility will ensure Waters customers continue to benefit from the most innovative chromatography particle R&D and the highest quality production in the industry."

The Taunton project is a noteworthy example of Waters’ capital allocation strategy, which prioritizes investing for long term growth and innovation. The return on this investment will be enhanced by the company's access to capital following U.S. tax reform, as well as the strong partnership of the Commonwealth of Massachusetts and the City of Taunton.

The company plans to employ LEED certification standards as well as state-of-the-art manufacturing and process technology to construct a new center-of-excellence that meets output, cost, quality and sustainability objectives. Specific plans remain subject to refinement, however the company expects the new plant will be operational by 2022. Until then, the existing Taunton facility will fully meet operational and growth needs.

Facts, background information, dossiers
  • precision chemistry
  • Waters
More about Waters
  • News

    Waters to Acquire Andrew Alliance

    Waters Corporation announced that it has entered into a definitive agreement to acquire Andrew Alliance, an innovator in specialty laboratory automation technology, including software and robotics. Andrew Alliance’s cloud-native software platform and modern interface dramatically improves t ... more

    Waters acquires DESI-MS technology from Prosolia

    Waters Corporation, Prosolia, Inc. and the Purdue Research Foundation announced that Waters® acquired exclusive rights to Desorption Electrospray Ionization (DESI) technology for all mass spectrometry applications from Prosolia and PRF. "The acquisition of DESI technology bolsters Waters' p ... more

    Waters and Malvern Panalytical collaborate to improve polymer characterization

    Waters Corporation announced that it entered into a co-marketing agreement with Malvern Panalytical to advance the analysis of polymers. By pairing the Waters ® ACQUITY ® Advanced Polymer Chromatography ® (APC ™ ) System with Malvern Panalytical’s OMNISEC ® REVEAL , R&D scientists can acces ... more

  • Products

    A New Tandem Quad MS for Quantification in Routine Analysis

    Maximum performance: more analytes per injection and larger concentration ranges - on a small footprint, at an affordable price more

    Self-optimizing LC-MS System for Biopharmaceutical Analyses

    No expert knowledge required | automatic setup | self-calibrating | self-optimizing | simplified audit preparation more

  • Catalogs

    Waters Quality Parts, Chromatography Columns and Supplies Catalog

    Our products are manufactured to industry benchmark quality requirements by our world-class manufacturing organization and supported by our highly skilled sales and support teams more

  • Videos

    Self-optimizing LC-MS System for Biopharmaceutical Analyses

    The BioAccord system enables even users without expert knowledge to generate and evaluate LC-MS data on the spot in the biopharmaceutical lab, tasks that until now had to be performed in centralized MS laboratories. From development to QC, the system makes the analysis of biotherapeutic pro ... more

    Minimal Method Development – Maximal GC Uptime

    Analytical laboratories working at full capacity are faced with the challenge of ensuring a comprehensive coverage of applications while working time and cost efficiently. This balancing act is now possible thanks to the Xevo TQ-GC mass spectrometer. Your results are reproducible even with ... more

  • Companies

    Waters GmbH

    Waters Corporation is a global leader in liquid chromatography (UPLC/HPLC), mass spectrometry (MS), rheology and thermal analysis. The business areas range from research & development, the manufacture and sale of analytical instruments, laboratory software products, column and sample prepar ... more

    Waters AG

    more

    Waters Ges.m.b.H.

    Since 1958 Waters offers complete solutions in High Performance Liquid Chromatography (HPLC). With our products and services we set the standards in HPLC. Waters Corporation is a multinational, publicly traded (NYSE: WAT) company headquartered in Milford, Massachusetts, USA. The company ha ... more